Browse by category

ReShape strengthens patent portfolio related to its Obalon Balloon System

ReShape Lifesciences has strengthened the patent portfolio related to its Obalon Balloon System, after to US Patent and Trademark Office...

EMA grants Orphan Drug Designation for Setmelanotide for treatment of acquired hypothalamic obesity

The European Medicines Agency (EMA) has issued a positive opinion on the Rhythm Pharmaceuticals’ orphan drug designation request for...

Altimmune completes dosing in the Phase 2 MOMENTUM trial

Altimmune has completed dosing (last subject last dose) in its 48-week Phase 2 MOMENTUM trial evaluating the efficacy and safety of...

First patients treated with ECLIPSIUM hernia repair system

The first patients have been treated with Tissium's ECLIPSIUM adhesive hernia repair system and have undergone laparoscopic ventral...

Viking begins VENTURE trial of dual glp-1/gip receptor agonist VK2735 for obesity

Viking Therapeutics has initiated a Phase 2 clinical trial of VK2735, the company's wholly-owned dual agonist of the glucagon-like...

Allurion launches Coach Iris generative AI-powered weight loss coach

Allurion Technologies has launched Coach Iris, a new generative AI-powered health coach designed to enhance outcomes within the Allurion...

Survodutide GLP-1 receptor dual agonist to be assessed in three global Phase III studies for obesity

Boehringer Ingelheim will advance survodutide, its glucagon/GLP-1 receptor dual agonist, into three registrational Phase III studies for...

Skooterama launches a bariatric scooters

Skooterama, a provider of mobility solutions, has expanded its product line with the launch of Bariatric Scooters. According to the...

Aardvark Therapeutics gains Rare Pediatric Disease Designation for Prader-Willi Syndrome

The FDA has granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...

MBX Biosciences gains FDA clearance to study MBX 1416 for post-bariatric hypoglycaemia

MBX Biosciences, a clinical stage biopharmaceutical company developing Precision Endocrine Peptide (PEP) therapeutics to treat an array...

Journal Watch 18/12/2024

2 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

3 hours ago

Obesity-related brain changes can be reversed after bariatric surgery

3 hours ago

Weekly Digest